Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

The GLP-1 Warfare in China: Pfizer and Innovent Clear Preliminary National Insurance Hurdles for a Billion-Citizen Market

29/06/2026 Published by Pharma Biz

Key Development China's National Healthcare Security Administration (NHSA) has officially released its updated regulatory ledger showing that next-generation GLP-1 receptor... Read more

Tags: #Global Trends

The Illiquidity Premium Valuation: Analyzing Tam Duc Heart Hospital’s Post-Bonus Share Surge

29/06/2026 Published by Pharma Biz

Key Development According to official regulatory disclosures submitted to the State Securities Commission of Vietnam, Tam Duc Heart Hospital Joint... Read more

Category: Uncategorized

Tags: #Vietnam

The 4-6 Golden Minutes That Decide Survival

27/06/2026 Published by Pharma Biz

The first few minutes can make the difference between life, death, and lasting disability. Every day, emergencies such as sudden... Read more

Category: Uncategorized

Tags: #Corporate Wellness

Beyond the spreadsheet: Four systemic failures in corporate decision rights

27/06/2026 Published by Pharma Biz

To streamline cross-functional collaboration, accelerate execution velocity, and mitigate internal friction within complex frameworks, enterprises frequently turn to decision-rights toolkits... Read more

Category: Uncategorized

Tags: #Human Resources

The fracture point in AI adoption: Why middle managers are drowning under corporate ambition

27/06/2026 Published by Pharma Biz

The divide between strategic vision and operational reality Global workforce analytics show that while approximately 88% of organizations have integrated... Read more

Category: Uncategorized

Tags: #Capability Development

Dominating the Pediatric Immunology Market: Analyzing AbbVie’s Strategic FDA Label Expansion for SKYRIZI®

27/06/2026 Published by Pharma Biz

Key Development Global biopharmaceutical powerhouse AbbVie (NYSE: ABBV) has officially secured U.S. Food and Drug Administration (FDA) approval expanding the... Read more

Category: Uncategorized

Tags: #Global Trends

Commercializing Neuraminidase Inhibitor Generics: Analyzing Alembic’s USFDA Approval for Tamiflu Oral Suspension

27/06/2026 Published by Pharma Biz

Key Development Indian pharmaceutical manufacturer Alembic Pharmaceuticals Ltd has secured final regulatory approval from the US Food and Drug Administration... Read more

Category: Uncategorized

Tags: #Global Trends

Consolidating Oncological Diagnostics: Analyzing Agilent’s $950 Million Acquisition of Biocare Medical

27/06/2026 Published by Pharma Biz

Key Development Global life sciences and diagnostics titan Agilent Technologies Inc. has officially finalized its previously announced acquisition of Biocare... Read more

Category: Uncategorized

Tags: #M&A

AI-Driven Target Discovery: Analyzing Boehringer Ingelheim’s Strategic T-Cell Alliance with Immunai

27/06/2026 Published by Pharma Biz

Key Development German pharmaceutical major Boehringer Ingelheim has finalized a comprehensive multi-project research collaboration with biotech innovator Immunai to identify... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 41 Page 42 Page 43 … Page 200 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members